GB202213124D0 - Psychiatric disorder - Google Patents

Psychiatric disorder

Info

Publication number
GB202213124D0
GB202213124D0 GBGB2213124.7A GB202213124A GB202213124D0 GB 202213124 D0 GB202213124 D0 GB 202213124D0 GB 202213124 A GB202213124 A GB 202213124A GB 202213124 D0 GB202213124 D0 GB 202213124D0
Authority
GB
United Kingdom
Prior art keywords
psychiatric disorder
psychiatric
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2213124.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
University of Helsinki
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
University of Helsinki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV, University of Helsinki filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority to GBGB2213124.7A priority Critical patent/GB202213124D0/en
Publication of GB202213124D0 publication Critical patent/GB202213124D0/en
Priority to PCT/EP2023/074294 priority patent/WO2024052329A1/en
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/30Psychoses; Psychiatry
    • G01N2800/301Anxiety or phobic disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB2213124.7A 2022-09-08 2022-09-08 Psychiatric disorder Ceased GB202213124D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2213124.7A GB202213124D0 (en) 2022-09-08 2022-09-08 Psychiatric disorder
PCT/EP2023/074294 WO2024052329A1 (en) 2022-09-08 2023-09-05 Panic disorder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2213124.7A GB202213124D0 (en) 2022-09-08 2022-09-08 Psychiatric disorder

Publications (1)

Publication Number Publication Date
GB202213124D0 true GB202213124D0 (en) 2022-10-26

Family

ID=83945210

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2213124.7A Ceased GB202213124D0 (en) 2022-09-08 2022-09-08 Psychiatric disorder

Country Status (2)

Country Link
GB (1) GB202213124D0 (en)
WO (1) WO2024052329A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2120997T3 (en) * 2006-12-21 2017-05-08 H Lundbeck As MODULATION OF PRO-NEUROTROPHIN ACTIVITY
US8703125B2 (en) * 2008-12-19 2014-04-22 H. Lundbeck A/S Modulation of the Vps10p-domain receptor family for the treatment of mental and behavioural disorders

Also Published As

Publication number Publication date
WO2024052329A1 (en) 2024-03-14

Similar Documents

Publication Publication Date Title
GB202105379D0 (en) Aptamers against SARS-CoV-2
GB202213094D0 (en) Psychiatric disorder
GB202213124D0 (en) Psychiatric disorder
GB202107267D0 (en) No title - early entry
GB201904364D0 (en) A method for predicting a psychiatric disorder
PT3959088T (en) Suspension adjustment assembly
CA213855S (en) Ledge profile
CA214200S (en) Harness
GB202306170D0 (en) NO TITLE - Early Entry
CA214906S (en) Multi-cooker
CA210085S (en) Muddler
EP3770606A4 (en) Method for judging psychiatric disorder
GB202304501D0 (en) Saddle
GB2601988B (en) Mount
GB202306293D0 (en) Saddles
GB202216953D0 (en) No title - early entry
GB202202369D0 (en) Feature H
GB202310165D0 (en) Securing means
GB202212764D0 (en) Disclosure
GB202210995D0 (en) Disclosure
GB202219070D0 (en) Improved n-plexer
GB202210979D0 (en) Improved flownmeter
GB202313469D0 (en) Harness
GB202301349D0 (en) Harness
GB202202380D0 (en) Feature l

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)